Gabelli & Co Investment Advisers’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-205,950
Closed -$2.54M 286
2024
Q4
$2.54M Buy
+205,950
New +$2.36M 0.43% 54

Other funds holding CDMO

Gabelli & Co Investment Advisers's CDMO Position: Q1 2025 in Review

Gabelli & Co Investment Advisers sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 205,950 shares — an estimated $2.54M sold.

Gabelli & Co Investment Advisers first reported a position in CDMO in Q4 2024 and held it in 1 quarter. The position peaked at $2.54M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Gabelli & Co Investment Advisers reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 205,950 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $2.54M.
  • Gabelli & Co Investment Advisers first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Avid Bioservices, Inc. Common Stock position peaked at $2.54M in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2025, filed 14 May 2025.